SP
BravenNow
Generate Biomedicines prices IPO at $16 per share
| USA | economy | ✓ Verified - investing.com

Generate Biomedicines prices IPO at $16 per share

#Generate Biomedicines #IPO pricing #NASDAQ:GENB #Biotechnology #AI-driven drug discovery #Public offering #Stock market #Biopharmaceutical

📌 Key Takeaways

  • Generate Biomedicines priced its IPO at $16 per share for 25 million shares
  • The IPO is expected to raise approximately $400 million before overallotment options
  • The company uses AI and machine learning for biologic medicine development
  • The IPO represents entry into public markets for the biotechnology firm

📖 Full Retelling

Generate Biomedicines, Inc. (NASDAQ:GENB) priced its initial public offering of 25 million shares of common stock at $16.00 per share in Somerville, Massachusetts, according to a press release issued Wednesday, marking the biotechnology company's entry into the public markets. The IPO pricing represents a significant milestone for Generate Biomedicines, a company focused on using artificial intelligence and machine learning to develop novel biologic medicines. By offering 25 million shares at $16 each, the company stands to raise approximately $400 million before any overallotment options are exercised, which will likely be used to advance the company's drug development pipeline and expand its AI-powered platform for biomedicine discovery. The company's decision to go public comes amid a period of increased investment in AI-driven biotechnology solutions, reflecting growing investor confidence in the intersection of artificial intelligence and pharmaceutical research.

🏷️ Themes

Biotechnology, IPO, Artificial Intelligence

📚 Related People & Topics

Public offering

Offering of securities of a company to the public

A public offering is the offering of securities of a company or a similar corporation to the public. Generally, the securities are to be publicly listed. In most jurisdictions, a public offering requires the issuing company to publish a prospectus detailing the terms and rights attached to the offer...

View Profile → Wikipedia ↗
Biotechnology

Biotechnology

Use of living systems and organisms to develop or make useful products

Biotechnology is a multidisciplinary field that involves the integration of natural sciences and engineering sciences in order to achieve the application of organisms and parts thereof for products and services. Specialists in the field are known as biotechnologists. The term biotechnology was first...

View Profile → Wikipedia ↗

Initial public offering

Type of securities offering in which a private company goes public

An initial public offering (IPO) or stock launch is a public offering in which shares of a company are sold to institutional investors and usually also to retail investors. An IPO is typically underwritten by one or more investment banks, who also arrange for the shares to be listed on one or more s...

View Profile → Wikipedia ↗
Stock market

Stock market

Place where stocks are traded

# Stock Market A **stock market**, also referred to as an **equity market** or **share market**, is the complex aggregation of buyers and sellers of stocks (shares). These financial instruments represent ownership claims on businesses and serve as a primary vehicle for capital allocation and corpor...

View Profile → Wikipedia ↗

Entity Intersection Graph

Connections for Public offering:

🌐 Restricted stock 2 shared
🌐 SEC filing 2 shared
🏢 Pizza Hut 1 shared
🌐 KFC 1 shared
🏢 National CineMedia 1 shared
View full profile
Original Source
SOMERVILLE, Mass. - Generate Biomedicines, Inc. (NASDAQ:GENB) priced its initial public offering of 25 million shares of common stock at $16.00 per share, according to a press release statement issued Wednesday.
Read full article at source

Source

investing.com

More from USA

News from Other Countries

🇬🇧 United Kingdom

🇺🇦 Ukraine